Clinical trials sponsored by Institut Bergonié

Phase breakdown

Conditions studied

Recruiting trials led by Institut Bergonié

• Circulating Tumor DNA After Neoadjuvant Chemotherapy
  NCT03357120 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma
  NCT06705335 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
  NCT04339218 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
  NCT05346848 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 10 locations

Common questions

How many trials is Institut Bergonié recruiting for?

Institut Bergonié is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.